在mRNACOVID-19疫苗注射后的血栓形成:一个病例系列
Sundeep Bekal1, George Husari2, Marcel Okura2
1Internal Medicine, Community Hospitalist Physician Group, Fresno, USA.
Cureus
|August 7, 2023
概括
使者RNA (mRNA) COVID-19疫苗是安全有效的. 存在罕见的血栓形成风险,但早期诊断和治疗可以确保完全康复. 接种疫苗的好处超过了风险.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 血栓形成的原因是血栓形成.
- 公共卫生 公共卫生
背景情况:
- 随着COVID-19的爆发,疫苗在全球健康方面发挥了至关重要的作用.
- 虽然腺病毒载体疫苗已经记录了血栓栓塞事件,但mRNA疫苗的数据有限.
- 了解疫苗接种后的罕见不良事件对于公共卫生和医疗实践至关重要.
研究的目的:
- 为了调查mRNA COVID-19疫苗接种后静脉血栓塞栓症 (VTE) 的发生情况.
- 提高医生对mRNA疫苗注射后潜在的血栓形成并发症的认识.
- 为了解与mRNA COVID-19疫苗相关的罕见不良影响做出贡献.
主要方法:
- 采用了一个案例系列设计.
- 该研究的重点是接种mRNA COVID-19疫苗后发展VTE的患者.
- 分析了来自四个不同的病例的临床数据.
主要成果:
- 在接受mRNACOVID-19疫苗后,四名患者发生了静脉血栓塞栓症.
- 这些事件代表了与mRNA COVID-19疫苗接种相关的罕见并发症.
- 早期诊断和及时治疗与患者的积极结果有关.
结论:
- 医生应该意识到mRNACOVID-19疫苗接种后血栓形成的可能性.
- mRNA COVID-19 疫苗的好处明显超过了罕见的疫苗接种后并发症的风险.
- 及时的医疗干预可以使疫苗相关的血栓形成完全恢复.
相关概念视频
Venous Thrombosis I: Introduction
12
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
12
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
14
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
14
Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Anticoagulant Drugs: Low-Molecular-Weight Heparins
753
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
753
Disorders of Hemostasis
991
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
991


